Mary Tolikas

Mary T. currently serves as Chief Innovation Officer at Dana-Farber Cancer Institute since April 2022. Prior to this role, Mary held the position of Chief Executive Officer at Wyss Center for Bio and Neuroengineering from June 2019 to December 2022. Mary also served as Executive Director for Special Projects in the Office of the Provost at Harvard University from January 2018 to May 2019 and as Director of Operations at the Wyss Institute for Biologically Inspired Engineering at Harvard University from January 2009 to June 2018. Earlier in Mary’s career, roles included Director of Business Development at Ansoft Corporation from 2004 to 2008 and Consultant at PA Consulting Group from 1999 to 2001. Mary holds a PhD in Electrical Engineering from the Massachusetts Institute of Technology and a BEng in Electrical Engineering and Computer Science from the University of Glasgow.